MedPath

BALMINIL SUPPOSITORIES ADULTS

BALMINIL SUPPOSITORIES ADULTS

Discontinued
DIN Number

00230553

Drug Class

Human

Market Date

Dec 31, 1951

Company
HC

rougier pharma division of ratiopharm inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00230553
AIG Number0402242003
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
R05FB02 COUGH SUPPRESSANTS AND EXPECTORANTS
Product Specifications
Dosage FormSuppository
Route of AdministrationRectal
AHFS Classification48:16.00
Health Canada Classification

ACTIVE INGREDIENTS (4)

DIBUNATE SODIUMActive
Strength: 40 MG
Monograph: DIBUNATE SODIUM
EUCALYPTOLActive
Strength: 200 MG
Monograph: EUCALYPTOL
MENTHOLActive
Strength: 50 MG
Monograph: MENTHOL
NIAOULI OILActive
Strength: 200 MG
Monograph: NIAOULI OIL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.